11 completed, 1 terminated. 12 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 12 | Completed 11, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow FluMist: new trials by email Literature Review of FluMist trials Research Report on FluMist
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection Fluzone®, FluMist® - Influenza, Healthy | Phase 1 | Completed | Stanford University | 80 | 2014-09-30 | 2020-02-13 |
| Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines A/swine/Missouri/4296424/2006 (H2N3) x A/Ann Arbor/6/60 ca (H2N3 MO 2006/AA ca), A/chicken/Hong Kong/G9/97 (H9N2) x A/Ann Arbor/6/60 ca (H9N2 G9/AA ca), 2012-2013 trivalent seasonal live attenuated influenza vaccine (FluMist®) - Influenza, Human | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 36 | 2012-09-01 | 2015-12-15 |
| Safety Study of FluMist With and Without Ampligen Poly I:Poly C12U 50 ug, Poly I:Poly C12U 200 ug, Poly I:Poly C12U 500 ug - Influenza, Human | Phase 1 / Phase 2 | Terminated | AIM ImmunoTech Inc. | 55 | 2012-04-01 | 2018-07-26 |
| Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza Vaccine Lactobacillus rhamnosus GG ATCC 53103 (LGG), Placebo, Live attenuated influenza vaccine - Healthy, Influenza | Phase 1 | Completed | Patricia L. Hibberd | 30 | 2012-02-01 | 2017-01-11 |
| Immunogenicity and Safety of Live Attenuated Influenza Vaccine (Flumist) Administered by Nasal and Sublingual Route Influenza vaccine - Healthy | Phase 1 | Completed | International Vaccine Institute | 40 | 2011-12-01 | 2013-12-23 |
| A Study of a Live Intranasal Influenza Vaccine in Children With Cancer FluMist, Inactivated influenza vaccine - Cancer | Phase 1 | Completed | St. Jude Children's Research Hospital | 56 | 2008-10-01 | 2011-10-13 |
| Probiotics to Enhance Immunogenicity of Influenza Vaccine in Healthy Adults Lactobacillus rhamnosus, placebo control, Influenza Virus Vaccine Live, Intranasal - Healthy | Phase 1 | Completed | Tufts Medical Center | 52 | 2007-09-01 | 2011-01-19 |
| A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist FluMist, Fluzone - Influenza | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 56 | 2005-09-01 | 2010-08-27 |
| Safety Study to Evaluate FluMist in Immunocompromised Children FluMist, Placebo - Cancer | Phase 1 | Completed | MedImmune LLC | 20 | 2005-08-01 | 2017-08-14 |
| Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults CAIV-T, Placebo - Healthy Japanese Male Adults | Phase 1 | Completed | MedImmune LLC | 45 | 2002-08-01 | 2012-01-26 |
| A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants CAIV-T - Healthy | Phase 1 | Completed | MedImmune LLC | 120 | 2002-05-01 | 2021-09-13 |
| Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents Cold-adapted live attenuated influenza vaccine (FluMist), Inactivated influenza vaccine (IAIV) - HIV Infections, Influenza | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 300 | 2021-11-01 |
Influenza, Human (10) · Neoplasms (2) · HIV Infections (1)
MedImmune LLC (3) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · AIM ImmunoTech Inc. (1) · International Vaccine Institute (1) · Patricia L. Hibberd (1) · St. Jude Children's Research Hospital (1) · Stanford University (1) · Tufts Medical Center (1)
United States (8) · Finland (1) · Puerto Rico (1) · South Korea (1)
Patricia L Hibberd, MD, PhD (2) · Robert Walker, MD (2) · Cecil Czerkinsky, Ph.D. (1) · Cornelia L Dekker, MD (1) · David R Strayer, MD (1) · John Treanor, MD (1) · Kyung-Sang Yu, M.D. (1) · Mark M Davis, PhD (1) · Myron J. Levin, MD (1) · Philip M Grant, MD (1) · Raburn Mallory, MD (1) · Silvana Carr, MD (1)
PMID 18299305, PMID 20581690, PMID 21285968, PMID 21496468, PMID 21846636, PMID 21949042, PMID 25128802
U19AI057229 (1)